학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 10건 | 목록 1~20
Academic Journal
van Hijfte L; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. l.vanhijfte@erasmusmc.nl.; Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. l.vanhijfte@erasmusmc.nl.; Geurts M; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; de Heer I; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Ghisai SA; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Balcioglu HE; Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Hoogstrate Y; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Vallentgoed WR; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Head R; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Luning R; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; van den Bosch T; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.; Westerman B; Department of Neurosurgery, Amsterdam UMC/VUMC, Amsterdam, The Netherlands.; Wesseling P; Department of Pathology, Amsterdam UMC/VUMC and Brain Tumour Center, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Joyce JA; Department of Oncology, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland.; Agora Cancer Center Lausanne and Swiss Cancer Center Léman, Lausanne, Switzerland.; French P; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. p.french@erasmusmc.nl.; Debets R; Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. j.debets@erasmusmc.nl.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Vallentgoed WR; Neurology Department Erasmus MC, Rotterdam, The Netherlands. w.r.vallentgoed@amsterdamumc.nl.; Hoogstrate Y; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; van Garderen KA; Radiology Department Erasmus MC, Rotterdam, The Netherlands.; van Hijfte L; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; van Dijk E; Pathology Department AUMC, Amsterdam, The Netherlands.; Kouwenhoven MCM; Neurology Department AUMC, Amsterdam, The Netherlands.; Niers JM; Neurology Department AUMC, Amsterdam, The Netherlands.; Draaisma K; Neurology and Neurosurgery Department UMCU, Utrecht, The Netherlands.; Martin I; Epidemiology and Biostatistics Department AUMC, Amsterdam, The Netherlands.; de Leng WWJ; Pathology Department UMCU, Utrecht, The Netherlands.; Tesileanu CMS; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; de Heer I; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; Diepeveen M; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; Lavrova A; Radiology Department Erasmus MC, Rotterdam, The Netherlands.; Eijk PP; Pathology Department AUMC, Amsterdam, The Netherlands.; Bühler M; Neurology Department University Hospital and University of Zurich, Zurich, Switzerland.; Wick W; Department of Neurology and Neuro-oncology Program, Heidelberg University Hospital, Heidelberg, Germany.; Clement PM; Department of Oncology, KU Leuven, Leuven, Belgium.; Sanson M; Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France.; Franceschi E; IRCCS Istituto Scienze Neurologiche di Bologna, Nervous System Medical Oncology Department, Bologna, Italy.; Gorlia T; EORTC Headquarters, Brussels, Belgium.; Golfinopoulos V; EORTC Headquarters, Brussels, Belgium.; Weller M; Neurology Department University Hospital and University of Zurich, Zurich, Switzerland.; Weiss T; Neurology Department University Hospital and University of Zurich, Zurich, Switzerland.; Robe PA; Neurology and Neurosurgery Department UMCU, Utrecht, The Netherlands.; Kros JM; Pathology Department Erasmus MC, Rotterdam, The Netherlands.; Smits M; Radiology Department Erasmus MC, Rotterdam, The Netherlands.; van de Wiel M; Epidemiology and Biostatistics Department AUMC, Amsterdam, The Netherlands.; Ylstra B; Pathology Department AUMC, Amsterdam, The Netherlands.; Verhaak RGW; Neurosurgery Department AUMC, Amsterdam, The Netherlands.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; van den Bent MJ; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; Westerman BA; Pathology Department AUMC, Amsterdam, The Netherlands.; Wesseling P; Pathology Department AUMC, Amsterdam, The Netherlands. p.wesseling@amsterdamumc.nl.; French PJ; Neurology Department Erasmus MC, Rotterdam, The Netherlands. p.french@erasmusmc.nl.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Academic Journal
Ghisai SA; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; van Hijfte L; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Tumour Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Vallentgoed WR; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Tesileanu CMS; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; de Heer I; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Kros JM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Sanson M; ICM Institute for Brain and Spinal Cords, Sorbonne University, Paris, France.; Gorlia T; EORTC Headquarters, Brussels, Belgium.; Wick W; Neurology Department, University Clinic Heidelberg, Heidelberg University & German Center, Heidelberg, Germany.; Vogelbaum MA; Neuro-Oncology Department, Moffitt Cancer Center, Tampa, FL, USA.; Brandes AA; Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Franceschi E; Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Clement PM; Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.; Nowak AK; Medical School, The University of Western Australia, Crawley, WA, Australia.; Golfinopoulos V; EORTC Headquarters, Brussels, Belgium.; van den Bent MJ; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; French PJ; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. p.french@erasmusmc.nl.; Hoogstrate Y; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
Academic Journal
van Garderen KA; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands.; Vallentgoed WR; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Lavrova A; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Niers JM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; de Leng WWJ; Department of Pathology, UMC Utrecht, Utrecht, The Netherlands.; Hoogstrate Y; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; de Heer I; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Ylstra B; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; van Dijk E; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Klein S; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Draaisma K; Department of Neurosurgery, UMC Utrecht, The Netherlands.; Robe PAJT; Department of Neurosurgery, UMC Utrecht, The Netherlands.; Verhaak RGW; Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands.; Westerman BA; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands.; French PJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; van den Bent MJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Kouwenhoven MCM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Kros JM; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.; Wesseling P; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Smits M; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Academic Journal
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Tesileanu CMS; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Vallentgoed WR; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Sanson M; Sorbonne Universités UPMC University of Paris 06, Inserm, CNRS, APHP, Institut du Cerveau et de la Moelle (ICM)-Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, 75013, Paris, France.; Taal W; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Clement PM; Department of Oncology, KU Leuven, Leuven, Belgium.; Department of General Medical Oncology, UZ Leuven, Leuven, Belgium.; Wick W; Neurologische Klinik und Nationales Zentrum für Tumorerkrankungen Universitätsklinik, Heidelberg, Germany.; Brandes AA; Medical Oncology Department, AUSL-IRCCS Scienze Neurologiche, Bologna, Italy.; Baurain JF; Medical Oncology Department, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium.; Chinot OL; Neuro-Oncology Division, Aix-Marseille University, AP-HM, Marseille, France.; Wheeler H; Northern Sydney Cancer Centre, St Leonards, NSW, 2065, Australia.; Gill S; Department Medical Oncology, Alfred Hospital, Melbourne, Australia.; Griffin M; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Rogers L; Department of Radiation Oncology, Barrow Neurological Institute, Phoenix, AZ, USA.; Rudà R; Department of Neuro-Oncology, City of Health and Science Hospital and University of Turin, Turin, Italy.; Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.; McBain C; Department of Clinical Oncology, The Christie NHS FT, Manchester, UK.; Reijneveld J; Brain Tumor Center Amsterdam and Department of Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Enting RH; Department of Neurology, UMCG, University of Groningen, Groningen, The Netherlands.; Caparrotti F; Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland.; Lesimple T; Department of Clinical Oncology, Comprehensive Cancer Center Eugène Marquis, Rennes, France.; Clenton S; Weston Park Hospital, Sheffield, UK.; Gijtenbeek A; Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Lim E; Department of Clinical Oncology, Plymouth Hospitals NHS Trust, Plymouth, UK.; de Vos F; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands.; Mulholland PJ; University College Hospital, London, UK.; Taphoorn MJB; MC Haaglanden, Den Haag, The Netherlands.; de Heer I; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Hoogstrate Y; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; de Wit M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Boggiani L; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Venneker S; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Oosting J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Erridge S; Edinburgh Centre for Neuro-Oncology, Western General Hospital, University of Edinburgh, Edinburg, UK.; Vogelbaum MA; Department of NeuroOncology, Moffitt Cancer Center, Tampa, FL, USA.; Nowak AK; School of Medicine and Pharmacology, University of Western Australia, 35 Stirling, Highway Crawley, WA, 6009, Australia.; CoOperative Group for NeuroOncology, University of Sydney, Camperdown, NSW, Australia.; Department of Medical Oncology, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA, 6009, Australia.; Mason WP; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.; Kros JM; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Wesseling P; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.; Aldape K; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.; Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Dubbink HJ; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Baumert B; Department of Radiation-Oncology (MAASTRO), Maastricht University Medical Center (MUMC) and GROW (School for Oncology), Maastricht, The Netherlands.; Institute of Radiation-Onology, Chur, Switzerland.; Golfinopoulos V; EORCT HQ, Brussels, Belgium.; Gorlia T; EORCT HQ, Brussels, Belgium.; van den Bent M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; French PJ; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. p.french@erasmusmc.nl.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
Academic Journal
van Hijfte L; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC University Medical Center, 3015 GD Rotterdam, the Netherlands.; Geurts M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.; Vallentgoed WR; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.; Eilers PHC; Department of Biostatistics, Erasmus MC University Medical Center, 3015 GD Rotterdam, the Netherlands.; Sillevis Smitt PAE; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.; Debets R; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC University Medical Center, 3015 GD Rotterdam, the Netherlands.; French PJ; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.
Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Academic Journal
Tesileanu CMS; Department of Neurology, The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Vallentgoed WR; Department of Neurology, The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; French PJ; Department of Neurology, The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; van den Bent MJ; Department of Neurology, The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: m.vandenbent@erasmusmc.nl.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Gao Y; Department of Neurology, Erasmus MC Cancer Institute; 3015 CD Rotterdam, The Netherlands. y.gao@erasmusmc.nl.; Vallentgoed WR; Department of Neurology, Erasmus MC Cancer Institute; 3015 CD Rotterdam, The Netherlands. w.vallentgoed@erasmusmc.nl.; French PJ; Department of Neurology, Erasmus MC Cancer Institute; 3015 CD Rotterdam, The Netherlands. p.french@erasmusmc.nl.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Vallentgoed WR
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어